Stock Price
15.72
Daily Change
0.57 3.73%
Monthly
-1.47%
Yearly
-15.83%
Q1 Forecast
14.69

Adma Biologics reported $236.62M in Ordinary Share Capital for its fiscal quarter ending in December of 2024.





Ordinary Share Capital Change Date
Adma Biologics USD 236.62M 242K Dec/2024
Alnylam Pharmaceuticals USD 132.38M 585K Dec/2025
BioCryst Pharmaceuticals USD 213.06M 2.54M Dec/2025
Minerva Neurosciences USD 1000 0 Sep/2024
Novavax USD 1.62M 211K Sep/2024
Omeros USD 611K 17K Dec/2023
Takeda JPY 1.58B 2K Dec/2025